I 2 =56.7%)
GLP-1 receptor agonists are synthetic versions of GLP-1 hormone that are used as prescribed medication to treat type 2 diabetes and lose weight
As tablets become more widely available, clearer communication around existing safety data, long-term research and the history of GLP-1 use in diabetes care could help reassure patients and improve confidence in treatment
Achievable plans for lasting outcomes By design, the program encourages long-lasting changes to health behaviors Achieving program goals drives better outcomes for your population Delivered as a key preventive health offering within your benefits ecosystem, or part of your daily use, personalized health platform to maximize ongoing support Financial benefits & outcomes you can count on 3:1 VOI Embedded within your personalized, daily use health, wellbeing, and navigation solution 99% Satisfaction Among participants who also improved their weight, activity, and mental wellbeing Better outcomes Transform outperforms similar programs' weight loss avg by 49%
Telling COPD and GERD Apart Distinguishing between COPD and GERD is vital for proper diagnosis and treatment planning
doi:10.3390/jcm12010145 PubMed PMID: 36614945